Loading...
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Immunogenicity in Clinical Practice and Drug Development: When is it Significant?

PropertyValue
has major subject area list Adaptive Immunity; Biological Products; Drug Development; Drug-Related Side Effects and Adverse Reactions; Models, Immunological
has minor subject area list Drug Monitoring; Humans; Monitoring, Immunologic; Risk Assessment; Societies, Scientific; United States; United States Food and Drug Administration
information resource reference Shakhnovich V, Meibohm B, Rosenberg A, Kierzek AM, Hasenkamp R, Funk RS, Thalhauser CJ, van der Graaf PH, Wang YC, Hamuro L. Immunogenicity in Clinical Practice and Drug Development: When is it Significant? Clin Transl Sci. 2020 03; 13(2):219-223.
label Immunogenicity in Clinical Practice and Drug Development: When is it Significant?

Search Criteria
  • Drug
  • Development